首页>
外国专利>
Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature
Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature
展开▼
机译:光动力疗法和抗VEGF药物联合治疗不需要的脉络膜新生血管
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of a combination of photodynamic therapy and an anti-VEGF agent in the treatment of conditions characterized by unwanted choroidal neovasculature is described. These conditions include wet age-related macular degeneration Preferred anti-VEGF agents are antibodies such as bevacizumab or ranibizumab Photosensitizers may be selected from green porphyrins such as BPD-MA (verteporfin) and the photodynamic activation of the photosensitizer may be accomplished using a reduced fluence rate. The use may further comprises an anti-inflammatory agent such a dexamethasone.
展开▼